---
provider: openscientist
model: openscientist-autonomous
cached: false
start_time: '2026-09-21T00:12:34.068047'
end_time: '2026-09-21T01:15:47.419244'
duration_seconds: 3793.35
template_file: templates/gene_hypothesis_deep_research.md
template_variables:
  organism: DESRO
  gene: K9IFT7
  gene_symbol: K9IFT7
  uniprot_accession: K9IFT7
  taxon_id: NCBITaxon:9430
  taxon_label: Desmodus rotundus
  focus_type: function_assignment
  hypothesis_slug: defensin-orthology-and-ccr6-binding
  hypothesis_text: Desmodus rotundus K9IFT7 (GenBank JAA44743.1), a beta-defensin-like
    protein, binds CCR6 (GO:0031731). Establish its exact orthology and assess whether
    primary donor receptor-binding experiments and sequence/clade conservation support
    this activity. Distinguish receptor binding from antimicrobial activity, salivary
    expression, and chemotaxis mediated by other receptors. Assess subfamily specificity
    without treating absence of a bat assay as refutation.
  term_context: No specific term context supplied.
  reference_context: No specific reference context supplied.
  source_file: genes/DESRO/K9IFT7/K9IFT7-ai-review.yaml
  source_selector: free-text
  source_context_yaml: "hypothesis: Desmodus rotundus K9IFT7 (GenBank JAA44743.1),\
    \ a beta-defensin-like protein, binds CCR6 (GO:0031731).\n  Establish its exact\
    \ orthology and assess whether primary donor receptor-binding experiments and\
    \ sequence/clade\n  conservation support this activity. Distinguish receptor binding\
    \ from antimicrobial activity, salivary\n  expression, and chemotaxis mediated\
    \ by other receptors. Assess subfamily specificity without treating\n  absence\
    \ of a bat assay as refutation.\nfocus_type: function_assignment\ncontext: []\n\
    reference_id: []"
provider_config:
  timeout: 3600
  max_retries: 3
  parameters:
    allowed_domains: []
    max_iterations: 3
    use_hypotheses: false
    investigation_mode: autonomous
    poll_interval: 30
    timeout: 7200
    save_artifacts: true
    artifact_max_bytes: 5242880
artifact_count: 4
artifact_sources:
  openscientist_artifacts_zip: 4
artifacts:
- filename: final_report.html
  path: openscientist_artifacts/final_report.html
  media_type: text/html
  source: openscientist_artifacts_zip
  data_storage_id: null
  description: OpenScientist final report
- filename: final_report.pdf
  path: openscientist_artifacts/final_report.pdf
  media_type: application/pdf
  source: openscientist_artifacts_zip
  data_storage_id: null
  description: OpenScientist final report
- filename: genes_DESRO_K9IFT7_K9IFT7_GO_decision_table.csv
  path: openscientist_artifacts/genes_DESRO_K9IFT7_K9IFT7_GO_decision_table.csv
  media_type: text/csv
  source: openscientist_artifacts_zip
  data_storage_id: null
  description: OpenScientist K9IFT7 GO decision table
- filename: genes_DESRO_K9IFT7_K9IFT7_evidence_matrix.csv
  path: openscientist_artifacts/genes_DESRO_K9IFT7_K9IFT7_evidence_matrix.csv
  media_type: text/csv
  source: openscientist_artifacts_zip
  data_storage_id: null
  description: OpenScientist K9IFT7 evidence matrix
---

## Question

# AIGR Gene Hypothesis Deep Research

You are evaluating one focused gene curation hypothesis for AI Gene Review.
This is not a general gene overview. Use the seed hypothesis and source context
below to search for evidence that supports, refutes, narrows, or competes with
the proposed curation decision.

## Target Gene

- **Organism code:** DESRO
- **Taxon:** Desmodus rotundus (NCBITaxon:9430)
- **Gene directory:** K9IFT7
- **Gene symbol:** K9IFT7
- **UniProt accession:** K9IFT7

## Focus

- **Focus type:** function_assignment
- **Hypothesis slug:** defensin-orthology-and-ccr6-binding
- **Source file:** genes/DESRO/K9IFT7/K9IFT7-ai-review.yaml
- **Source selector:** free-text

## Seed Hypothesis

Desmodus rotundus K9IFT7 (GenBank JAA44743.1), a beta-defensin-like protein, binds CCR6 (GO:0031731). Establish its exact orthology and assess whether primary donor receptor-binding experiments and sequence/clade conservation support this activity. Distinguish receptor binding from antimicrobial activity, salivary expression, and chemotaxis mediated by other receptors. Assess subfamily specificity without treating absence of a bat assay as refutation.

## Term and Decision Context

No specific term context supplied.

## Reference Context

No specific reference context supplied.

## Source Context YAML

```yaml
hypothesis: Desmodus rotundus K9IFT7 (GenBank JAA44743.1), a beta-defensin-like protein, binds CCR6 (GO:0031731).
  Establish its exact orthology and assess whether primary donor receptor-binding experiments and sequence/clade
  conservation support this activity. Distinguish receptor binding from antimicrobial activity, salivary
  expression, and chemotaxis mediated by other receptors. Assess subfamily specificity without treating
  absence of a bat assay as refutation.
focus_type: function_assignment
context: []
reference_id: []
```

## Research Objective

Build a focused report that helps a curator decide whether this hypothesis
should affect the gene review. Address the focus type directly:

1. For an existing GO annotation decision, evaluate whether the current action
   is justified, too strong, too weak, or should change.
2. For a proposed replacement or new GO term, evaluate whether the term is
   biologically supported, too broad, too narrow, or missing key qualifiers.
3. For a computational prediction, evaluate whether the prediction is correct,
   less precise than existing knowledge, uncertain, or likely wrong because of
   paralog overannotation, frequency bias, pathway context, or in vitro-only
   activity.
4. For a core-function hypothesis, evaluate whether the proposed activity,
   process, and location represent the gene product's primary function rather
   than a downstream effect, pleiotropic phenotype, or context-specific role.
5. For a function-assignment hypothesis, evaluate whether the gene product
   directly has the stated GO term/function. Treat the prior review action, if
   any, as intentionally blinded unless it appears in the supplied context.

Use primary literature whenever possible. Prefer PMID citations and include DOI
citations when no PMID is available. Treat reviews and database records as
orientation unless they contain directly relevant synthesized evidence that is
clearly labeled as review-level or database-level support.

Evaluate the hypothesis from the supplied seed context, primary literature, and
publicly accessible bioinformatics resources. Local `*-bioinformatics` analyses,
when they already exist in the repository, are intentionally withheld from this
prompt so the report can be compared against them after the run. Use public
sequence, domain, structure, orthology, localization, interaction, or dataset
checks when they are useful for the specific hypothesis. If a resource or tool
cannot be accessed programmatically, say so plainly; never fabricate a result.
Report computational results conservatively and distinguish direct results from
inference.

## Required Output

### Executive Judgment

Give a concise verdict: supported, partially supported, unresolved, weakly
supported, over-annotated, or refuted. Explain the reasoning and the most
important caveats.

### Evidence Matrix

Create a table with one row per important evidence item:

- Citation (PMID preferred)
- Evidence type (direct assay, mutant phenotype, localization, interaction,
  structural/evolutionary, computational, review/database)
- Supports / refutes / qualifies / competing
- Claim tested
- Key finding
- Organism, tissue, cell type, or assay context
- Confidence and limitations

### GO Curation Implications

State the likely curation action as a lead requiring curator verification. If
GO terms are involved, explain whether the evidence supports an MF, BP, or CC
term, and whether the term should be retained, removed, generalized, made more
specific, or treated as non-core. Avoid using "protein binding" as a final
recommendation unless no more informative term is supported.

### Mechanistic Scope

Describe the immediate molecular or cellular function being tested. Separate
direct gene-product activity from downstream phenotypes, pathway consequences,
developmental outcomes, disease manifestations, or effects inferred only from
loss of function.

### Conflicts and Alternatives

Identify evidence that conflicts with the seed hypothesis or suggests an
alternative interpretation, including paralog confusion, organism-specific
differences, isoform-specific findings, experimental artifacts, or database
carry-over.

### Knowledge Gaps

List explicit uncertainties that matter for curation. For each gap, state what
was checked, why the gap matters, and what evidence or experiment would resolve
it.

### Discriminating Tests

Recommend concrete assays, perturbations, datasets, or comparative analyses that
would most efficiently distinguish this hypothesis from alternatives.

### Curation Leads

Provide candidate updates for the review, clearly labeled as leads requiring
curator verification. Include candidate references with exact snippets to verify,
candidate replacement or new GO terms, possible action changes, suggested
questions, and suggested experiments.

If the provider supports artifacts, save provenance for any analysis you run — the
executed code together with its output (computed values, plot, or table), not just
a summary figure — alongside artifact-friendly tables such as an evidence matrix,
GO decision table, or comparison table. Genuine computed provenance is more
valuable than a hand-drawn summary, and you must not synthesize a figure that
implies an analysis you did not actually run. These artifacts are important
provenance for hypothesis-level review.


## Output

# AIGR Deep Research — K9IFT7 (DESRO): beta-defensin orthology and CCR6 binding

**Gene:** K9IFT7 / *Desmodus rotundus* (vampire bat, NCBITaxon:9430) — GenBank JAA44743.1, RefSeq XP_071076263.1
**Focus:** function_assignment — does K9IFT7 directly have GO:0031731 "CCR6 chemokine receptor binding"?
**Source:** genes/DESRO/K9IFT7/K9IFT7-ai-review.yaml (free-text seed)

---

## Executive Judgment

**Verdict: PARTIALLY SUPPORTED (homology-plausible but unverified; not the core function).**

- **Orthology to the beta-defensin-1 (DEFB1) subfamily is well supported.** K9IFT7 is a canonical 67-aa beta-defensin (Pfam PF00711, InterPro IPR001855, PANTHER PTHR21388:SF9 "BETA-DEFENSIN 1", SUPFAM SSF57392), with the intact 6-cysteine motif (inter-Cys gaps 7-5-10-7-1), cationic net charge (+4), and highest mature-peptide identity to human **DEFB1 (hBD-1, 59.1%)** among the human panel tested (hBD-3 53.7%, DEFB118 52.3%, hBD-2 40.9%, hBD-4 36.4%). Identity is only *moderate*, and bat beta-defensins are an expanded, fast-evolving multigene family, so strict 1:1 orthology to DEFB1 is not proven.
- **CCR6 binding (GO:0031731) is a phylogenetic prediction, evidence code IEA:TreeGrafter** — grafted onto the DEFB1 subfamily. There is **no direct assay of K9IFT7 or any bat defensin**.
- The prediction is **plausible** because the closest human ortholog, DEFB1, has *direct* experimental CCR6 interaction (PMID 25122636), and K9IFT7 retains a documented CCR6-chemotaxis determinant (N-terminal Leu; PMID 20022113).
- **But it is contested and non-core.** Whether CCR6 is a genuine functional beta-defensin receptor has been directly challenged (PMID 17705135), beta-defensins also use CCR2 (PMID 20483750), and receptor usage varies by defensin/cell type (hBD-1 ≠ hBD-2 for neutrophils, PMID 15009427). The gene's *documented* role (Vampirome, PMID 23411029) is **salivary-gland antimicrobial defense**, not chemotaxis.

**Bottom line for the curator:** the CCR6-binding term is defensible only as a low-confidence, homology-transferred (IEA), **non-core** molecular function. Do **not** upgrade it to an experimental code; do **not** treat the absence of a bat assay as refutation. The best-supported annotations are antimicrobial defense response and extracellular localization.

---

## Evidence Matrix

| Citation | Evidence type | Supports/Refutes/Qualifies/Competing | Claim tested | Key finding | Context | Confidence & limitations |
|---|---|---|---|---|---|---|
| UniProt K9IFT7 (DB record) | computational/database | Qualifies | Term provenance | GO:0031731 is **IEA:TreeGrafter** (phylogenetic graft to PANTHER SF9 "beta-defensin 1"); no experimental code | *D. rotundus* TrEMBL entry | High that it is IEA; weakest GO evidence tier |
| This report (NW alignment) | structural/evolutionary (computational) | Supports (orthology) | Which human defensin is closest | Mature K9IFT7 most identical to **DEFB1/hBD-1 (59.1%)**; canonical 6-Cys motif, net +4, N-term Leu | in-silico vs human panel | Moderate; simple global alignment, not a phylogeny/tree reconciliation |
| PMID 23411029 (Vampirome) | localization/expression (primary) | Qualifies/Competing | Documented function | Bat salivary **accessory submandibular gland antimicrobial** (with lysozyme, lactotransferrin); no CCR6 assay | *D. rotundus* glands, RNA-seq + LC-MS/MS | High for antimicrobial/secreted role; silent on CCR6 |
| PMID 10521347 (Yang 1999, Science) | direct assay/binding (primary) | Supports (family-level) | Beta-defensin–CCR6 binding | Human beta-defensin chemotactic via CCR6; **competitively displaced ¹²⁵I-LARC/CCL20** on CCR6 transfectants (foundational MF evidence) | CCR6-transfected cells, iDC, memory T cells | High; peptide used was primarily hBD-2, not DEFB1/hBD-1 |
| PMID 25122636 (Diao 2014) | direct interaction (primary) | Supports | Ortholog CCR6 binding | **Human DEFB1 interacts with CCR6** and triggers Ca²⁺ mobilization | Human sperm | High for DEFB1; different tissue/species than K9IFT7 |
| PubMed (no hits) | absence of evidence | Qualifies | Bat defensin function | **No functional characterization of any chiropteran/bat beta-defensin** (CCR6 or antimicrobial assay) was found | Chiroptera | Confirms annotation rests entirely on cross-mammal homology |
| PMID 29207656 | direct assay (primary) | Supports | CCR6 as DEFB1-linked receptor | CCR6 required for ligand-induced CatSper activation | Human sperm | Corroborates DEFB1–CCR6 axis |
| PMID 20022113 (Tyrrell 2010) | mutant/structure-function (primary) | Supports (plausibility) | CCR6 determinants | N-terminal **Leu/Ile essential** for CCR6 chemotaxis; K9IFT7 mature N-term = Leu | Defb14 peptide derivatives | Determinant present in K9IFT7 = plausibility, not proof |
| PMID 17705135 (Soruri 2007) | direct assay (primary) | **Competing/Refutes (family-level)** | Is CCR6 a real beta-defensin receptor | "**CCR6 is not a functional receptor for beta-defensins**"; CCR6-transfectants unresponsive to hBD-2/-3 | Human/murine cells, CCR6 transfectants | Direct conflict; challenges the whole annotation basis |
| PMID 20483750 (Röhrl 2010) | direct interaction (primary) | Qualifies/Competing | Receptor exclusivity | hBD-2/-3 (and mouse orthologs) bind **CCR2**, not only CCR6 | HEK293-CCR2, human monocytes | Shows multiple receptors; CCR6 not sole/obligate |
| PMID 15009427 (Niyonsaba 2004) | direct assay (primary) | Qualifies | hBD-1 vs hBD-2 receptor usage | "**hBD-2, but not hBD-1**" chemoattracts neutrophils via CCR6 | TNF-treated human neutrophils | Receptor/activity is defensin- and cell-type-specific |
| PMID 21434867 (Morgera 2011) | cellular assay (primary) | Qualifies | CCR6 dependence | iDC responses to hBD2 occur via "**CCR6-dependent and -independent**" mechanisms | Human iDC/monocytes | CCR6 partial contributor |

---

## GO Curation Implications

- **GO:0031731 "CCR6 chemokine receptor binding" (MF):** Evidence supports retaining it **only as a low-confidence, homology-based (IEA) prediction flagged non-core**. It should **not** be generalized to bare "protein binding" (uninformative) nor promoted to an experimental code. A curator may reasonably choose to (a) keep the IEA as-is with a not-core note, or (b) down-weight/remove it given the direct family-level conflict (PMID 17705135) and the lack of any bat/DEFB1-ortholog-specific salivary assay. **Lead, requires curator verification.**
- **Better-supported annotations to prioritize:** GO:0050830 / GO:0050829 (defense response to Gram-positive/negative bacterium, BP), GO:0002227 (innate immune response in mucosa, BP), GO:0005576 (extracellular region, CC) — all consistent with the primary Vampirome evidence (PMID 23411029) and the Pfam/InterPro defensin identity. These represent the gene product's core function.
- If any experimental-code MF for receptor binding is ever added, it must derive from an assay of K9IFT7 (or a demonstrated bat DEFB1 ortholog), not transfer from human DEFB1.

---

## Mechanistic Scope

The tested molecular function is **direct binding of the secreted mature beta-defensin peptide to the CC chemokine receptor CCR6** (a GPCR), which for human beta-defensins couples to Gαi and drives chemotaxis of immature dendritic cells / memory T cells and Ca²⁺ mobilization. This is distinct from, and must be separated from:
- **Antimicrobial activity** (membrane-disruptive killing of bacteria/fungi) — the evidenced core role in bat saliva.
- **Salivary/glandular expression** (localization, not activity).
- **Chemotaxis via other receptors** (CCR2, or CCR6-independent membrane effects).
For K9IFT7 specifically, CCR6 binding is *inferred by homology*, not demonstrated; the antimicrobial role is *documented*.

---

## Conflicts and Alternatives

1. **Family-level receptor conflict:** PMID 17705135 directly reports CCR6 is *not* a functional beta-defensin receptor — a fundamental challenge to the annotation's premise.
2. **Multiple/alternative receptors:** CCR2 usage (PMID 20483750) and CCR6-independent mechanisms (PMID 21434867) mean "CCR6 binding" may overstate specificity.
3. **Defensin-specific variability:** hBD-1 behaves differently from hBD-2 (PMID 15009427); transferring a CCR6 phenotype across the whole SF9 subfamily risks paralog over-annotation.
4. **Orthology uncertainty:** 59% mature identity to DEFB1 with an expanded bat beta-defensin repertoire means K9IFT7 may be a bat-specific paralog rather than a true DEFB1 ortholog; TreeGrafter subfamily assignment can misplace fast-evolving lineage-specific defensins.
5. **Context mismatch:** the strongest DEFB1–CCR6 evidence is in human sperm (PMID 25122636/29207656), a context unrelated to a bat salivary antimicrobial.

---

## Knowledge Gaps

| Gap | What was checked | Why it matters | Resolving evidence |
|---|---|---|---|
| No assay of K9IFT7 (or any bat defensin) vs CCR6 | PubMed; Vampirome | Annotation rests entirely on homology transfer | Direct binding/chemotaxis assay of recombinant K9IFT7 on CCR6⁺ cells |
| True orthology (DEFB1 vs bat-specific paralog) | NW identity, PANTHER SF9 | Determines validity of subfamily transfer | Phylogenetic tree reconciliation of chiropteran beta-defensin cluster; synteny |
| Correct mature N-terminus / cleavage | UniProt Chain 24-67 vs domain 34-66 | N-terminal Leu is a CCR6 determinant; propiece removal could alter it | Proteomic N-terminal sequencing of the salivary peptide |
| Whether CCR6 is a genuine receptor at all | PMID 17705135 vs 25122636 | Field disagreement undermines the term | Reproducible receptor-transfectant binding across labs |

---

## Discriminating Tests

1. **Direct receptor assay:** recombinant/synthetic K9IFT7 (correctly folded, 3 disulfides) in a CCR6-transfectant binding + chemotaxis/Ca²⁺-flux assay, with CCR6-knockout and CCL20 competition controls.
2. **Receptor panel:** test CCR2 and CCR6 side-by-side to establish specificity vs the known CCR2 cross-reactivity.
3. **Antimicrobial vs chemotactic split:** MIC assays (Gram±) to anchor the core function; compare potency to chemotactic EC50.
4. **Phylogenomics:** reconcile the *D. rotundus* beta-defensin cluster against human DEFB1/DEFB4/DEFB103 to confirm or refute DEFB1 orthology and detect lineage-specific expansion.
5. **Structure:** AlphaFold model (AlphaFoldDB K9IFT7 exists) + electrostatics to check the CCR6-binding surface and N-terminal helix.

---

## Curation Leads (require curator verification)

- **Action lead:** Keep GO:0031731 only as **IEA/homology, non-core**, or down-weight/remove; add an explicit note that the sole basis is TreeGrafter transfer from human DEFB1 and that CCR6 as a beta-defensin receptor is contested. **Do not** replace with generic "protein binding."
- **Candidate references to attach/verify:**
  - PMID 25122636 — direct human DEFB1–CCR6 interaction (supports, ortholog).
  - PMID 17705135 — CCR6 not a functional beta-defensin receptor (conflict/caveat).
  - PMID 20483750 — CCR2 as alternative receptor (caveat).
  - PMID 20022113 — N-terminal Leu/Ile CCR6 determinant (plausibility).
  - PMID 23411029 — primary source; salivary antimicrobial role (core function).
- **Candidate core-function terms to prioritize (better supported):** GO:0050830, GO:0050829, GO:0002227 (BP, defense/innate immunity); GO:0005576 (CC).
- **Suggested curator questions:** Is a phylogenetic-only MF receptor-binding term desired on a lineage-specific TrEMBL bat defensin? Should the annotation be qualified with a "non-core"/"inferred" note pending a direct assay?
- **Suggested experiment:** recombinant K9IFT7 CCR6-transfectant binding + chemotaxis assay (see Discriminating Tests).

---

## Provenance Artifacts

Computed tables saved alongside the gene directory (`genes/DESRO/K9IFT7/`):
- `K9IFT7_GO_decision_table.csv` — per-term curation leads (MF/BP/CC, evidence codes, basis).
- `K9IFT7_evidence_matrix.csv` — literature evidence matrix with stance tally.

Orthology identities were computed by Needleman–Wunsch alignment of the K9IFT7 mature peptide against a UniProt-fetched human/mouse beta-defensin panel (executed in-session; DEFB1 59.1% > hBD-3 53.7% > DEFB118 52.3%). The 6-cysteine motif (inter-Cys gaps 7-5-10-7-1), net charge +4, and N-terminal Leu were computed directly from the sequence.

## Limitations

TrEMBL (unreviewed) entry; **no functional data exist for any chiropteran/bat beta-defensin** (PubMed returned no hits), so every functional claim is cross-mammal homology transfer. Orthology inference used a simple global-alignment identity rather than a full phylogeny, and the human mature-peptide boundaries were not cleanly parsed for all panel members (alignments partly include propieces); nonetheless the DEFB1-closest ranking was stable across both runs, with hBD-3 (53.7%) and DEFB118 (52.3%) as near neighbors — i.e., subfamily assignment is confident but *exact* DEFB1 orthology is only moderately supported. The foundational beta-defensin–CCR6 evidence (Yang 1999, PMID 10521347) used hBD-2; direct DEFB1–CCR6 evidence (Diao 2014, PMID 25122636) is human sperm, a non-salivary context. All computational orthology statements are inference, clearly distinguished from the primary literature.


## Artifacts

- [OpenScientist final report](openscientist_artifacts/final_report.html)
- [OpenScientist final report](openscientist_artifacts/final_report.pdf)
- [OpenScientist K9IFT7 GO decision table](openscientist_artifacts/genes_DESRO_K9IFT7_K9IFT7_GO_decision_table.csv)
- [OpenScientist K9IFT7 evidence matrix](openscientist_artifacts/genes_DESRO_K9IFT7_K9IFT7_evidence_matrix.csv)